Rachel Jug

8PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersIntensive careApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Clinical chemistry (incl. diagnostics)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 20, 2024
The negative outlook: Long-term follow up of ThyroSeq negative and low-risk nodules.

Raquel A Perry, Megan F Lee, Rachel C Jug

|Dec 11, 2023
Intravenous albumin utilization audit at a large community hospital.

Rachel Jug, Jeannie Callum, Theodora Ruijs

|Mar 05, 2021
A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury.

Rachel Jug, Waseem Anani, Jeannie Callum

|Dec 28, 2020
Multisite Quality Improvement Study of a Patient-Pathologist Consultation Program.

Rachel Jug, Adam L Booth, Anne F Buckley

|Apr 28, 2020
High-risk and intermediate-high-risk results from the ThyroSeq v2 and v3 thyroid genomic classifier are associated with neoplasia: Independent performance assessment at an academic institution.

Rachel Jug, Wen-Chi Foo, Claudia Jones

|Apr 12, 2018
Molecular testing for indeterminate thyroid nodules: Performance of the Afirma gene expression classifier and ThyroSeq panel.

Rachel C Jug, Michael B Datto, Xiaoyin Sara Jiang

Pageof 2

Frequent Collaborators

3 joint publications

Xiaoyin Sara Jiang

2 joint publications

Jeannie Callum

1 joint publications

Raquel A Perry

1 joint publications

Wen-Chi Foo